Difucosyllacto-N-hexaose (a)

• 分子结构分类: 有机化合物 - 有机氧化合物
• 英文名称: Difucosyllacto-N-hexaose (a)
• 英文别名: N-[2-[2-[5-acetamido-6-[3,5-dihydroxy-2-(hydroxymethyl)-6-(1,2,4,5-tetrahydroxy-6-oxohexan-3-yl)oxyoxan-4-yl]oxy-2-(hydroxymethyl)-4-(3,4,5-trihydroxy-6-methyloxan-2-yl)oxyoxan-3-yl]oxy-3,5-dihydroxy-6-(hydroxymethyl)oxan-4-yl]oxy-6-(hydroxymethyl)-5-[3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy-4-(3,4,5-trihydroxy-6-methyloxan-2-yl)oxyoxan-3-yl]acetamide
• 化学式: C₅₂H₈₈N₂O₃₉
• 分子量: 1365.2
• InChiKey: QBJOQIQKFXHKEG-UHFFFAOYSA-N

计算性质

• 辛醇/水分配系数(LogP)：
  -14.7
• 重原子数：
  93
• 可旋转键数：
  26
• 环数：
  7.0
• sp3杂化的碳原子比例：
  0.94
• 拓扑面积：
  650
• 氢给体数：
  24
• 氢受体数：
  39

文献信息

• HUMAN MILK FORTIFIER COMPOSITION
  申请人：Société des Produits Nestlé S.A.

  公开号：EP3716960A1

  公开（公告）日：2020-10-07
• [EN] HUMAN MILK FORTIFIER COMPOSITION<br/>[FR] COMPOSITION DE FORTIFIANT DU LAIT HUMAIN
  申请人：NESTLE SA

  公开号：WO2020127161A1

  公开（公告）日：2020-06-25

  The present invention relates to a preterm human milk fortifier composition, more specifically to a preterm milk fortifier composition providing 2'-FL and /or LNFP-I in amounts that are missing in human milk of women who gave birth to a preterm infant. In particular the present invention relates to a fortifier composition designed for infants as a supplement to preterm human breast milk at the time the infant leaves the hospital (discharge) and after. The invention furthermore relates to the use of said preterm human milk fortifier composition.